These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15592497)

  • 21. Direct regulation of the minichromosome maintenance complex by MYCN in neuroblastoma.
    Koppen A; Ait-Aissa R; Koster J; van Sluis PG; Ora I; Caron HN; Volckmann R; Versteeg R; Valentijn LJ
    Eur J Cancer; 2007 Nov; 43(16):2413-22. PubMed ID: 17826980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overall genomic pattern is a predictor of outcome in neuroblastoma.
    Janoueix-Lerosey I; Schleiermacher G; Michels E; Mosseri V; Ribeiro A; Lequin D; Vermeulen J; Couturier J; Peuchmaur M; Valent A; Plantaz D; Rubie H; Valteau-Couanet D; Thomas C; Combaret V; Rousseau R; Eggert A; Michon J; Speleman F; Delattre O
    J Clin Oncol; 2009 Mar; 27(7):1026-33. PubMed ID: 19171713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.
    Alaminos M; Dávalos V; Ropero S; Setién F; Paz MF; Herranz M; Fraga MF; Mora J; Cheung NK; Gerald WL; Esteller M
    Cancer Res; 2005 Apr; 65(7):2565-71. PubMed ID: 15805250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression profiling of 1p35-36 genes in neuroblastoma.
    Janoueix-Lerosey I; Novikov E; Monteiro M; Gruel N; Schleiermacher G; Loriod B; Nguyen C; Delattre O
    Oncogene; 2004 Aug; 23(35):5912-22. PubMed ID: 15195138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exon array analysis reveals neuroblastoma tumors have distinct alternative splicing patterns according to stage and MYCN amplification status.
    Guo X; Chen QR; Song YK; Wei JS; Khan J
    BMC Med Genomics; 2011 Apr; 4():35. PubMed ID: 21501490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New insights into the genetic basis of neuroblastoma].
    Speleman F; De Preter K; Hoebeeck J; Van Roy N; Vandesompele J
    Verh K Acad Geneeskd Belg; 2007; 69(4):167-96. PubMed ID: 17821957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bladder cancer outcome and subtype classification by gene expression.
    Blaveri E; Simko JP; Korkola JE; Brewer JL; Baehner F; Mehta K; Devries S; Koppie T; Pejavar S; Carroll P; Waldman FM
    Clin Cancer Res; 2005 Jun; 11(11):4044-55. PubMed ID: 15930339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caspase-8 gene expression in neuroblastoma.
    Casciano I; Banelli B; Croce M; De Ambrosis A; di Vinci A; Gelvi I; Pagnan G; Brignole C; Allemanni G; Ferrini S; Ponzoni M; Romani M
    Ann N Y Acad Sci; 2004 Dec; 1028():157-67. PubMed ID: 15650242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positional gene expression analysis identifies 12q overexpression and amplification in a subset of neuroblastomas.
    Su WT; Alaminos M; Mora J; Cheung NK; La Quaglia MP; Gerald WL
    Cancer Genet Cytogenet; 2004 Oct; 154(2):131-7. PubMed ID: 15474148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reanalysis of neuroblastoma expression profiling data using improved methodology and extended follow-up increases validity of outcome prediction.
    Schramm A; Mierswa I; Kaderali L; Morik K; Eggert A; Schulte JH
    Cancer Lett; 2009 Sep; 282(1):55-62. PubMed ID: 19349112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
    Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma.
    Yang Q; Zage P; Kagan D; Tian Y; Seshadri R; Salwen HR; Liu S; Chlenski A; Cohn SL
    Clin Cancer Res; 2004 Dec; 10(24):8493-500. PubMed ID: 15623630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of persistent cytomegalovirus infection on human neuroblastoma cell gene expression.
    Hoever G; Vogel JU; Lukashenko P; Hofmann WK; Komor M; Doerr HW; Cinatl J
    Biochem Biophys Res Commun; 2005 Jan; 326(2):395-401. PubMed ID: 15582591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
    Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
    J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression profiling of head and neck squamous cell carcinoma using cDNA microarrays.
    Gottschlich S; Ambrosch P; Cordes C; Görögh T; Schreiber S; Häsler R
    Int J Oncol; 2006 Sep; 29(3):605-13. PubMed ID: 16865276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expulsion of amplified MYCN from homogenously staining chromosomal regions in neuroblastoma cell lines after cultivation with cisplatin, doxorubicin, hydroxyurea, and vincristine.
    Prochazka P; Hrabeta J; Vícha A; Eckschlager T
    Cancer Genet Cytogenet; 2010 Jan; 196(1):96-104. PubMed ID: 19963143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of DEIN, a novel gene with high expression levels in stage IVS neuroblastoma.
    Voth H; Oberthuer A; Simon T; Kahlert Y; Berthold F; Fischer M
    Mol Cancer Res; 2007 Dec; 5(12):1276-84. PubMed ID: 18171985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome.
    Spitz R; Oberthuer A; Zapatka M; Brors B; Hero B; Ernestus K; Oestreich J; Fischer M; Simon T; Berthold F
    Genes Chromosomes Cancer; 2006 Dec; 45(12):1130-42. PubMed ID: 16958102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.
    Wang Q; Diskin S; Rappaport E; Attiyeh E; Mosse Y; Shue D; Seiser E; Jagannathan J; Shusterman S; Bansal M; Khazi D; Winter C; Okawa E; Grant G; Cnaan A; Zhao H; Cheung NK; Gerald W; London W; Matthay KK; Brodeur GM; Maris JM
    Cancer Res; 2006 Jun; 66(12):6050-62. PubMed ID: 16778177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease.
    Oberthuer A; Warnat P; Kahlert Y; Westermann F; Spitz R; Brors B; Hero B; Eils R; Schwab M; Berthold F; Fischer M
    Cancer Lett; 2007 Jun; 250(2):250-67. PubMed ID: 17126996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.